AVE 50.0% 0.3¢ avecho biotechnology limited

chart update, page-130

  1. 513 Posts.
    Dear KC and Forum,

    I can assure you I am not Esra Ogru, in fact I have on occasion written a full post outlining my contempt for that chameleon only to have binned it rather than bore you all with my ramblings.

    Instead I have focussed my time reviewing the science and literature that has been released on TPM, and I can categorically say that I am fully satisfied with this Tocopheryl Phosphate Mixture and its ability to enhance actives.

    I have also spoken with the scientists and executives at Phosphagenics over the last few weeks, and again I am satisfied they are about to bring enormous change in, as to how they go about their business. The new COO has very good pharmaceutical credentials as well as being a BPharm, the company without Esra Ogru is in a far better place in my humble opinion.

    Novartis is about to include TPM in its Diclofenac diethylammonium (Voltaren) Gel, and for a large company to do that with what is already a gold standard product that salutes and validates the TPM technology for me.

    BSW
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(50.0%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $3.925K 1.486M

Buyers (Bids)

No. Vol. Price($)
62 100922609 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20853279 7
View Market Depth
Last trade - 13.10pm 15/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.